EMERYVILLE, Calif., Feb. 7, 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that NovaBay will have a booth at the Annual Dialysis Conference, held February 8-11, 2014 in Atlanta, GA. Dr. Allan G. Kavalich, a nephrologist based in San Bernardino, CA will be present in the NovaBay booth and available to answer questions on the research he conducted with NeutroPhase®* in 2013. NeutroPhase is a 0.01% pure hypochlorous acid in saline with no bleach impurities, unlike Dakin and other Dakin-like solutions. In laboratory testing NeutroPhase has been shown to be 100-fold more antimicrobial than Dakin and 100-fold safer than Dakin.
Help employers find you! Check out all the jobs and post your resume.
